In particular, NSD2 overexpression has been reported in a variety of solid tumors, including metastatic PCa (in comparison to primary tumors) and is associated with biochemical recurrence, with in vitro studies in PCa cell lines indicating NSD2’s role in the progression of PCa. This evidence concerns the gene NSD2 and posterior cortical atrophy.